Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS

Cited by (1,060)

Items 901–1,000 of 1,060

  1. Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis
    Manfredi, Giovanni, Kawamata, Hibiki · 2016 · Neurobiology of Disease
  2. C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population
    Mario Sabatelli, Francesca Luisa Conforti, Marcella Zollino, Gabriele Mora, Maria Rosaria Monsurrò, Paolo Volanti, Kalliopi Marinou, Fabrizio Salvi, Massimo Corbo, Fabio Giannini et al. · 2012 · Neurobiology of Aging
  3. Synaptic Paths to Neurodegeneration: The Emerging Role of TDP-43 and FUS in Synaptic Functions
    Shuo‐Chien Ling · 2018 · Neural Plasticity
  4. Identification of GGC repeat expansion in the NOTCH2NLC gene in amyotrophic lateral sclerosis
    Yanchun Yuan, Zhen Liu, Xuan Hou, Wanzhen Li, Jie Ni, Ling Huang, Yiting Hu, Pan Liu, Xiaorong Hou, Jin Xue et al. · 2020 · Neurology
  5. Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models
    Yuanjing Liu, Jean‐Cosme Dodart, Hélène Tran, Shaunna S. Berkovitch, Maurine C. Braun, Michael Byrne, Ann Fiegen Durbin, Xiao Shelley Hu, Naoki Iwamoto, Hyun Gyung Jang et al. · 2021 · Nature Communications
  6. Two FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degeneration
    Wei Shao, Tiffany W. Todd, Yanwei Wu, Caroline Y. Jones, Jimei Tong, Karen R. Jansen‐West, Lillian M. Daughrity, Jinyoung Park, Yuka Mitsuhashi Koike, Aishe Kurti et al. · 2022 · Science
  7. Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery
    Wu, Xiaolei, Yang, Zhangzhong, Zou, Jinjun, Gao, Huile, Shao, Zhenhua, Li, Chuanzhou, Lei, Peng · 2025 · Signal Transduction and Targeted Therapy
  8. Brain morphologic changes in asymptomatic C9orf72 repeat expansion carriers
    Renée Walhout, Ruben Schmidt, Henk‐Jan Westeneng, Esther Verstraete, Meinie Seelen, Wouter van Rheenen, Marcel A. de Reus, Michael A. van Es, Jeroen Hendrikse, Jan Herman Veldink et al. · 2015 · Neurology
  9. Inferring short tandem repeat variation from paired-end short reads
    Minh Duc Cao, Edward Tasker, Kai Willadsen, Michael Imelfort, Sailaja Vishwanathan, Sridevi Sureshkumar, Sureshkumar Balasubramanian, Mikael Bodén A · 2013 · Nucleic Acids Research
  10. Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes
    Matthew R. Livesey, Dario Magnani, Elaine M. Cleary, Navneet A. Vasistha, Owain T. James, Bhuvaneish Thangaraj Selvaraj, Karen Burr, David Story, Christopher E. Shaw, Peter C. Kind et al. · 2016 · Stem Cells
  11. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs
    Hawrot, James, Imhof, Sophie, Wainger, Brian J. · 2020 · Neurobiology of Disease
  12. Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP‐43 pathology and not associated with aggregated forms of dipeptide repeat proteins
    Davidson, Y., Robinson, A. C., Liu, X., Wu, D., Troakes, C., Rollinson, S., Masuda‐Suzukake, M., Suzuki, G., Nonaka, T., Shi, J. et al. · 2016 · Neuropathology and Applied Neurobiology
  13. A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis
    Cooper-Knock, Johnathan, Green, Claire, Altschuler, Gabriel, Wei, Wenbin, Bury, Joanna J., Heath, Paul R., Wyles, Matthew, Gelsthorpe, Catherine, Highley, J. Robin, Lorente-Pons, Alejandro et al. · 2017 · Acta Neuropathologica Communications
  14. Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not
    John Hardy, Ekaterina A. Rogaeva · 2013 · Experimental Neurology
  15. De novo FUS mutations are the most frequent genetic cause in early-onset German ALS patients
    Annemarie Hübers, Walter Just, Angela Rosenbohm, Kathrin Müller, Nicolai Marroquin, Ingrid Goebel, Josef Högel, Hölger Thiele, Janine Altmüller, Peter Nürnberg et al. · 2015 · Neurobiology of Aging
  16. The genotype–phenotype landscape of familial amyotrophic lateral sclerosis in Australia
    Emily P. McCann, Kelly L. Williams, Jennifer A. Fifita, Ingrid S. Tarr, John Joseph O'Connor, Dominic B. Rowe, Garth A. Nicholson, Ian P. Blair · 2017 · Clinical Genetics
  17. Atypical parkinsonian syndromes: a general neurologist's perspective
    Angela Deutschländer, Owen A. Ross, Dennis W. Dickson, Zbigniew K. Wszołek · 2017 · European Journal of Neurology
  18. Using Genome Sequence to Enable the Design of Medicines and Chemical Probes
    Alicia J. Angelbello, Jonathan L. Chen, Jessica L. Childs‐Disney, Peiyuan Zhang, Zi-Fu Wang, Matthew David Disney · 2018 · Chemical Reviews
  19. Driven to decay: Excitability and synaptic abnormalities in amyotrophic lateral sclerosis
    Matthew Joseph Fogarty · 2018 · Brain Research Bulletin
  20. New pathologic mechanisms in nucleotide repeat expansion disorders
    Caitlin M. Rodriguez, Peter K. Todd · 2019 · Neurobiology of Disease
  21. Identification of expanded repeats in NOTCH2NLC in neurodegenerative dementias
    Bin Jiao, Lu Zhou, Yafang Zhou, Ling Weng, Xinxin Liao, Yun Tian, Lina Guo, Xixi Liu, Zhenhua Yuan, Xuewen Xiao et al. · 2020 · Neurobiology of Aging
  22. The Wide World of Coacervates: From the Sea to Neurodegeneration
    Emanuele Astoricchio, Caterina Alfano, Lawrence Rajendran, Piero Andrea Temussi, Annalisa Pastore · 2020 · Trends in Biochemical Sciences
  23. Structure of the C9orf72 ARF GAP complex that is haploinsufficient in ALS and FTD
    Ming-Yuan Su, Simon A. Fromm, Roberto Zoncu, James H. Hurley · 2020 · Nature
  24. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics
    Bidisha Roy, Erica J. Lee, Teresa Li, Maria Rampersaud · 2022 · Genes
  25. Redox Regulation in Amyotrophic Lateral Sclerosis
    Sonam Parakh, Damian M. S. Spencer, Mark A. Halloran, Kai Ying Soo, Julie D. Atkin · 2013 · Oxidative Medicine and Cellular Longevity
  26. Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development
    Adam L. Boxer, Michael Gold, Edward D. Huey, Fen‐Biao Gao, Edward A. Burton, Tiffany W. Chow, Aimee W. Kao, Blair R. Leavitt, Bruce T. Lamb, Megan E. Grether et al. · 2012 · Alzheimer s & Dementia
  27. Nuclear localization of MBNL1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins
    Yoshihiro Kino, Chika Washizu, Masaru Kurosawa, Yoko Oma, Nobutaka Hattori, Shoichi Ishiura, Nobuyuki Nukina · 2014 · Human Molecular Genetics
  28. Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians
    Jennifer Roggenbuck, Adam D. Quick, Stephen J. Kolb · 2016 · Genetics in Medicine
  29. Psychosis in Frontotemporal Dementia
    Shunichiro Shinagawa, Shinichiro Nakajima, Eric Plitman, Ariel Graff‐Guerrero, Masaru Mimura, Kazuhiko Nakayama, Bruce L. Miller · 2014 · Journal of Alzheimer s Disease
  30. Regulation of Brain Cholesterol: What Role Do Liver X Receptors Play in Neurodegenerative Diseases?
    Kévin Mouzat, Aleksandra Chudinova, Anne Sophie Polge, Jovana Kantar, William Camu, Cédric Raoul, Serge Lumbroso · 2019 · International Journal of Molecular Sciences
  31. Gene Therapy in Amyotrophic Lateral Sclerosis
    Ton Fang, Goun Je, Peter Pacut, Kiandokht Keyhanian, Jeff Gao, Mehdi Ghasemi · 2022 · Cells
  32. RNA-binding proteins in neurological diseases
    Hua-Lin Zhou, Marie Mangelsdorf, JiangHong Liu, Li Zhu, Jane Y. Wu · 2014 · Science China Life Sciences
  33. Amyotrophic Lateral Sclerosis and Skeletal Muscle: An Update
    Orietta Pansarasa, Daniela Rossi, Angela Lucia Berardinelli, Cristina Cereda · 2013 · Molecular Neurobiology
  34. C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers
    Patrizia Rizzu, Cornelis Blauwendraat, Sasja Heetveld, Emily M. Lynes, Melissa Castillo-Lizardo, Ashutosh Dhingra, Elwira Pyż, Markus A. Hobert, Matthis Synofzik, Javier Simón‐Sánchez et al. · 2016 · Acta Neuropathologica Communications
  35. ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export
    Ashley V. Boehringer, Krystine Garcia‐Mansfield, Gurkaran M. Singh, Nadine Bakkar, Patrick Pirrotte, Robert P. Bowser · 2017 · Scientific Reports
  36. High-resolution AFM structure of DNA G-wires in aqueous solution
    Krishnashish Bose, Christopher Jacques Lech, Brahim Heddi, Anh Tuân Phan · 2018 · Nature Communications
  37. Spinocerebellar ataxias
    Bing‐Wen Soong, Patrick J. Morrison · 2018 · Handbook of clinical neurology
  38. Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia
    Borroni, Barbara, Benussi, Alberto, Archetti, Silvana, Galimberti, Daniela, Parnetti, Lucilla, Nacmias, Benedetta, Sorbi, Sandro, Scarpini, Elio, Padovani, Alessandro · 2015 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  39. Early dipeptide repeat pathology in a frontotemporal dementia kindred with C9ORF72 mutation and intellectual disability
    Malcolm J. Proudfoot, Nick J Gutowski, Dieter Edbauer, David A. Hilton, Mark Stephens, Julia Rankin, Ian R. Mackenzie · 2014 · Acta Neuropathologica
  40. Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration
    Cindy Maurel, Audrey Dangoumau, Sylviane Marouillat, Céline Brulard, Anna A. Chami, Rudolf C. Hergesheimer, Philippe Corcia, Hélène Blasco, Christian Robert Andres, Patrick Vourc’h · 2018 · Molecular Neurobiology
  41. Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation
    Junhao Li, Manoj K. Jaiswal, Jo-fan Chien, Alexey Kozlenkov, Jinyoung Jung, Ping Zhou, Mahammad Gardashli, Luc Pregent, Erica Engelberg-Cook, Dennis W. Dickson et al. · 2023 · Nature Communications
  42. C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9
    Björn Friedhelm Vahsen, Sumedha Nalluru, Georgia R. Morgan, Lucy E Farrimond, Emily Carroll, Yinyan Xu, Kaitlyn M. L. Cramb, Benazir Amein, Jakub Scaber, Antigoni Katsikoudi et al. · 2023 · Nature Communications
  43. Mutant SOD 1 inhibits ER ‐Golgi transport in amyotrophic lateral sclerosis
    Julie D. Atkin, Manal A. Farg, Kai Ying Soo, Adam K. Walker, Mark A. Halloran, Bradley J. Turner, Phillip Nagley, Malcolm Kenneth Horne · 2013 · Journal of Neurochemistry
  44. Astrocytes show reduced support of motor neurons with aging that is accelerated in a rodent model of ALS
    Melanie M. Das, Clive N. Svendsen · 2014 · Neurobiology of Aging
  45. Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene
    Marka van Blitterswijk, Bianca Mullen, Aleksandra Wojtas, Michael G. Heckman, Nancy N. Diehl, Matthew Baker, Mariely DeJesus‐Hernandez, Patricia H. Brown, Melissa Erin Murray, Ging‐Yuek Robin Hsiung et al. · 2014 · Molecular Neurodegeneration
  46. Spreading of amyotrophic lateral sclerosis lesions--multifocal hits and local propagation?
    Tsuyoshi SEKIGUCHI, Tadashi Kanouchi, Kazumoto Shibuya, Yu‐ichi Noto, Y. Yagi, A. Inaba, Keisuke Abe, Sonoko Misawa, Satoshi Orimo, Toshimitsu Kobayashi et al. · 2013 · Journal of Neurology Neurosurgery & Psychiatry
  47. Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP‐43 Q331K transgenic mouse model of amyotrophic lateral sclerosis
    Kirat K. Chand, Kah Meng Lee, John D. Lee, Hao Qiu, Emily F. Willis, Nickolas A. Lavidis, Massimo A. Hilliard, Peter G. Noakes · 2018 · The FASEB Journal
  48. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2
    Osaka, Mayuko, Ito, Daisuke, Suzuki, Norihiro · 2016 · Biochemical and Biophysical Research Communications
  49. Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G 4 C 2 ) repeat expansion in vitro and in vivo ALS models
    Bush, Jessica A., Aikawa, Haruo, Fuerst, Rita, Li, Yue, Ursu, Andrei, Meyer, Samantha M., Benhamou, Raphael I., Chen, Jonathan L., Khan, Tanya, Wagner-Griffin, Sarah et al. · 2021 · Science Translational Medicine
  50. Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology
    Peet, Bradley T., Spina, Salvatore, Mundada, Nidhi, La Joie, Renaud · 2021 · Neurotherapeutics
  51. Therapeutic neuroprotective agents for amyotrophic lateral sclerosis
    Rachna S. Pandya, Haining Zhu, Wei Li, Robert P. Bowser, Robert Max Friedlander, Xin Wang · 2013 · Cellular and Molecular Life Sciences
  52. Genome-Wide Analysis of the Heritability of Amyotrophic Lateral Sclerosis
    Margaux F. Keller, Luigi Ferrucci, Andrew Singleton, Pentti J. Tienari, Hannu Laaksovirta, Gabriella Restagno, Adriano Chiò, Bryan J. Traynor, Mike A. Nalls · 2014 · JAMA Neurology
  53. The mouse C9ORF72 ortholog is enriched in neurons known to degenerate in ALS and FTD
    Naoki Suzuki, Asif Mirza Maroof, Florian T. Merkle, Kathryn Koszka, Atsushi Intoh, Ian K. G. Armstrong, Rob Moccia, Brandi N. Davis‐Dusenbery, Kevin C. Eggan · 2013 · Nature Neuroscience
  54. Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD
    Lindsey D. Goodman, Mercedes Prudencio, Nicholas J. Kramer, Luis F. Martinez-Ramirez, Ananth R. Srinivasan, Matthews Lan, Michael J Parisi, Yongqing Zhu, Jeannie Chew, Casey N. Cook et al. · 2019 · Nature Neuroscience
  55. Cryo-EM structure of C9ORF72–SMCR8–WDR41 reveals the role as a GAP for Rab8a and Rab11a
    Dan Tang, Jingwen Sheng, Liangting Xu, Xiechao Zhan, Jiaming Liu, Hui Jiang, Xiaoling Shu, Xiaoyu Liu, Tizhong Zhang, Lan Jiang et al. · 2020 · Proceedings of the National Academy of Sciences
  56. Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives
    Tiziana Bonifacino, Roberta Arianna Zerbo, Matilde Balbi, Carola Torazza, Giulia Frumento, Ernesto Fedele, Giambattista Bonanno, Marco Milanese · 2021 · International Journal of Molecular Sciences
  57. Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions
    Min‐Young Noh, Hyuk Sung Kwon, Min‐Soo Kwon, Minyeop Nahm, Hee Kyung Jin, Jae‐sung Bae, Seung Hyun Kim · 2025 · Molecular Neurodegeneration
  58. Modeling ALS and FTD with iPSC-derived neurons
    Sebum Lee, Eric Jinsheng Huang · 2015 · Brain Research
  59. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS
    Yazi Diana Ke, Annika van Hummel, Claire H. Stevens, Amadeus Gladbach, Stefania Ippati, Mian Bi, Wei S. Lee, Sarah Krüger, Julia van der Hoven, Alexander M. Volkerling et al. · 2015 · Acta Neuropathologica
  60. VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient
    Marka van Blitterswijk, Michael A. van Es, Max Koppers, Wouter van Rheenen, Jelena Medic, Helenius Jurgen Schelhaas, Anneke J. van der Kooi, Marianne de Visser, Jan Herman Veldink, Leonard H. van den Berg · 2012 · Neurobiology of Aging
  61. Therapeutic Development in Amyotrophic Lateral Sclerosis
    Monica Bucchia, Agnese Ramirez, Valeria Parente, Chiara Simone, Monica Nizzardo, Francesca Magri, Sara Dametti, Stefania Paola Corti · 2015 · Clinical Therapeutics
  62. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis
    Patricia S. Estes, Scott G. Daniel, Abigail P. McCallum, Ashley V. Boehringer, Alona S. Sukhina, Rebecca A. Zwick, Daniela C. Zarnescu · 2013 · Disease Models & Mechanisms
  63. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation
    Marc Suárez‐Calvet, Oriol Dols‐Icardo, Albert Lladó, Raquel Sánchez‐Valle, I. Hernandez, Guillem Amer, Sofía Antón‐Aguirre, Daniel Andres Alcolea, Juan Fortea, Isidró Ferrer et al. · 2013 · Journal of Neurology Neurosurgery & Psychiatry
  64. Absence of consensus in diagnostic criteria for familial neurodegenerative diseases
    Susan Byrne, Marwa Elamin, Peter Bede, Orla M. Hardiman · 2012 · Journal of Neurology Neurosurgery & Psychiatry
  65. Targeting TDP-43 phosphorylation by Casein Kinase-1δ inhibitors: a novel strategy for the treatment of frontotemporal dementia
    Carolina Alquézar, Irene G. Salado, Ana de la Encarnación, Daniel I. Pérez, Fermín Moreno, Carmen Gil, Adolfo López de Munaín, Ana Martı́nez, Ángeles Martín‐Requero · 2016 · Molecular Neurodegeneration
  66. Topology of a G-quadruplex DNA formed by C9orf72 hexanucleotide repeats associated with ALS and FTD
    Bo Zhou, Changdong Liu, Yanyan Geng, Guang Zhu · 2015 · Scientific Reports
  67. Exploring new pathways of neurodegeneration in ALS: The role of mitochondria quality control
    Gloria M. Palomo, Giovanni Manfredi · 2014 · Brain Research
  68. Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant
    Andrew King, Safa Al‐Sarraj, Claire Troakes, Bradley N. Smith, Satomi Maekawa, Mariangela Iovino, Maria Grazia Spillantini, Christopher E. Shaw · 2012 · Acta Neuropathologica
  69. RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum
    Matthew Thomas, Javier Alegre‐Abarrategui, Richard Wade‐Martins · 2013 · Brain
  70. The roles of intrinsic disorder-based liquid-liquid phase transitions in the “Dr. Jekyll–Mr. Hyde” behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
    Vladimir Nikolaevich Uversky · 2017 · Autophagy
  71. MAP4K4 Activation Mediates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis
    Chen Wu, Michelle Evelyn Watts, Lee L. Rubin · 2019 · Cell Reports
  72. Non-coding RNAs in Nervous System Development and Disease
    Beatrice Salvatori, Silvia Biscarini, Mariangela Morlando · 2020 · Frontiers in Cell and Developmental Biology
  73. TFEB/Mitf links impaired nuclear import to autophagolysosomal dysfunction in C9-ALS
    Kathleen M. Cunningham, Kirstin Maulding, Kai Ruan, Mümine Şentürk, Jonathan C. Grima, Hyun Sung, Zhongyuan Zuo, Helen Song, Junli Gao, Sandeep Kumar Dubey et al. · 2020 · eLife
  74. Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders
    Antonis Roussos, Katerina Kitopoulou, Fivos Borbolis, Konstantinos Palikaras · 2023 · Biomolecules
  75. Solution structure of a DNA quadruplex containing ALS and FTD related GGGGCC repeat stabilized by 8-bromodeoxyguanosine substitution
    Jasna Brčić, Janez Plavec · 2015 · Nucleic Acids Research
  76. Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis
    Matthew B. Harms, Janet Cady, Craig Mitchell Zaidman, Paul Cooper, Taha Bali, Peggy Allred, Carlos Cruchaga, Michael W. Baughn, Ryan T. Libby, Alan Pestronk et al. · 2013 · Neurobiology of Aging
  77. Characterization of DNA G-quadruplex species forming from C9ORF72 G4C2-expanded repeats associated with amyotrophic lateral sclerosis and frontotemporal lobar degeneration
    Primož Šket, Jure Pohleven, Anja Kovanda, Maja Štalekar, Vera Župunski, Matja Zalar, Janez Plavec, Boris Rogelj · 2014 · Neurobiology of Aging
  78. Neuromuscular effects of G93A-SOD1 expression in zebrafish
    Stacey A. Sakowski, J. Simon Lunn, A.S. Busta, Sang Su Oh, Grettel J. Zamora-Berridi, Madeline Palmer, Andrew A Rosenberg, Stephen G Philip, James J. Dowling, Eva L. Feldman · 2012 · Molecular Neurodegeneration
  79. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis
    Christophe Verbeeck, Qiudong Deng, Mariely DeJesus‐Hernandez, Georgia Taylor, Carolina Ceballos‐Diaz, Jannet Kocerha, Todd Eliot Golde, Pritam Das, Rosa Rademakers, Dennis W. Dickson et al. · 2012 · Molecular Neurodegeneration
  80. Common and Divergent Mechanisms in Developmental Neuronal Remodeling and Dying Back Neurodegeneration
    Avraham Yaron, Oren Schuldiner · 2016 · Current Biology
  81. Opening up the DNA methylome of dementia
    Raúl Delgado‐Morales, Manel Esteller · 2017 · Molecular Psychiatry
  82. Diagnosis and Clinical Management of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
    Stephen A. Goutman · 2017 · CONTINUUM Lifelong Learning in Neurology
  83. C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment
    Cacace, Rita, Van Cauwenberghe, Caroline, Bettens, Karolien, Gijselinck, Ilse, van der Zee, Julie, Engelborghs, Sebastiaan, Vandenbulcke, Mathieu, Van Dongen, Jasper, Bäumer, Veerle, Dillen, Lubina et al. · 2013 · Neurobiology of Aging
  84. ALS and frontotemporal dysfunction: a review
    Achi, Eugene Y., Rudnicki, Stacy A. · 2012 · Neurology Research International
  85. Longitudinal imaging in C9ORF72 mutation carriers: relationship to phenotype
    Floeter, Mary Kay, Bageac, Devin, Danielian, Laura E., Braun, Laura E., Traynor, Bryan J., Kwan, Justin Y. · 2016 · NeuroImage: Clinical
  86. Antisense Therapy in Neurology
    Joshua K. Lee, Toshifumi Yokota · 2013 · Journal of Personalized Medicine
  87. Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?
    Laura Robelin, José‐Luis González de Aguilar · 2014 · BioMed Research International
  88. Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration
    EunRan R. Suh, Edward B. Lee, Donald Neal, Elisabeth McCarty Wood, Jon B. Toledo, Lior Rennert, David John Irwin, Corey T. McMillan, Bryan L. Krock, Lauren B. Elman et al. · 2015 · Acta Neuropathologica
  89. Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases
    Riccardo Cristofani, V. Crippa, P. Rusmini, M.E. Cicardi, M. Meroni, Nausicaa Valentina Licata, Gessica Sala, Elisa Giorgetti, Christopher Grunseich, M. Galbiati et al. · 2017 · Autophagy
  90. Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study
    Taha Omer, Eoin Finegan, Siobhán Hutchinson, Mark A. Doherty, Alice Vajda, Russell Lewis McLaughlin, Niall P Pender, Orla M. Hardiman, Peter Bede · 2017 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  91. Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD
    Hongbo Chen, Mark W. Kankel, Susan C. Su, Steve Han, Dimitry Ofengeim · 2018 · Cell Death and Differentiation
  92. Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
    Tereza Filipi, Zuzana Heřmanová, Jana Turečková, Ondřej Vaňátko, Miroslava Anděrová · 2020 · Journal of Clinical Medicine
  93. Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion
    Joke De Vocht, Jeroen Blommaert, Martijn Devrome, Ahmed Radwan, Donatienne Van Weehaeghe, Maxim De Schaepdryver, Jenny Ceccarini, Ahmadreza Rezaei, Georg Schramm, June van Aalst et al. · 2020 · JAMA Neurology
  94. Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers—a developmental disorder
    Dorothée E. Lulé, Hans‐Peter Müller, Julia Finsel, Patrick Weydt, Antje Knehr, Ivar Winroth, Peter Munch Andersen, Jochen Hans Weishaupt, Ingo Uttner, Jan Kassubek et al. · 2020 · Journal of Neurology Neurosurgery & Psychiatry
  95. Loss of TMEM106B potentiates lysosomal and FTLD‐like pathology in progranulin‐deficient mice
    Georg Werner, Markus Daμμe, Martin H. Schludi, Johannes S. Gnörich, Karin Wind-Mark, Katrin Fellerer, Benedikt Wefers, Wolfgang Wurst, Dieter Edbauer, Matthias Brendel et al. · 2020 · EMBO Reports
  96. Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis
    Kim A. Staats, David Borchelt, Malú G. Tansey, James P. Wymer · 2022 · Molecular Neurodegeneration
  97. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies
    Alexandra L. Young, Jacob W. Vogel, John L. Robinson, Corey T. McMillan, Rik Ossenkoppele, David A. Wolk, David John Irwin, Lauren B. Elman, Murray Grossman, Virginia M.‐Y. Lee et al. · 2023 · Brain
  98. The neurotrophic properties of progranulin depend on the granulin E domain but do not require sortilin binding
    Louis De Muynck, Sarah Herdewyn, Sander Beel, Wendy Scheveneels, Ludo Van Den Bosch, Wim Robberecht, Philip Van Damme · 2013 · Neurobiology of Aging
  99. Detection of Slipped-DNAs at the Trinucleotide Repeats of the Myotonic Dystrophy Type I Disease Locus in Patient Tissues
    Michelle M. Axford, Yuh‐Hwa Wang, Masayuki Nakamori, Maria Zannis‐Hadjopoulos, Charles A. Thornton, Christopher E. Pearson · 2013 · PLoS Genetics
  100. Golgi Fragmentation in ALS Motor Neurons. New Mechanisms Targeting Microtubules, Tethers, and Transport Vesicles
    Georg Haase, Cathérine Rabouille · 2015 · Frontiers in Neuroscience